SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-016893
Filing Date
2021-02-09
Accepted
2021-02-09 21:18:38
Documents
2
Period of Report
2021-02-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm214979-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm214979-6_3seq1.xml 3 1608
2 EXHIBIT 24 tm214979d6_ex-24.htm EX-24 7064
  Complete submission text file 0001104659-21-016893.txt   10076
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1226 CHARTER LANE AMBLER PA 19002
Business Address
Thorell Marella (Reporting) CIK: 0001826323 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40034 | Film No.: 21608870